Literature DB >> 22218518

Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients.

Maria Rita Polo Gascón1, Claudio Garcia Capitão, Jorge Casseb, Maria Cezira Fantini Nogueira-Martins, Jerusa Smid, Augusto César Penalva de Oliveira.   

Abstract

UNLABELLED: The HAM/TSP caused by HTLV-1 infection usually affects patients to disabling states, and sometimes can lead them to paraplegia presenting symptoms of depression and anxiety, impacting on quality of life.
OBJECTIVE: The purpose of this study was to evaluate the frequency of depression and anxiety and its impact on quality of life in HTLV-1-infected TSP/HAM patients.
MATERIAL AND METHODS: This was a cross-sectional study including 67 asymptomatic (control group) and 63 with TSP/HAM subjects. The instruments used were a demographic questionnaire, scales for anxiety and depression diagnosis (BDI and BAI), questionnaire for the assessment of Quality of Life of the World Health Organization (WHOQOL-Brief) and neurological scale to measure the disability level (Osame's Disability Status Scale). All patients had HTLV-I diagnosis by serological and molecular approaches, monitored at Instituto de Infectologia Emílio Ribas from May 2008 to July 2009. Data were analyzed statistically by frequencies, the Mann-Whitney test and the Spearman correlation test. Data among groups were analyzed and correlated with functional and severity aspects.
RESULTS: The results showed that patients with HAM/TSP compared to asymptomatic carriers had higher rates of depression (p < 0.001) and anxiety (p < 0.001), and impairment on quality of life in the areas of: dissatisfaction with health (p < 0.001), physical (p < 0.001) and the environment (p = 0.003). The main factors that correlated with levels of depression and anxiety and the domains of the WHOQOL-brief were: education, family income and social class.
CONCLUSION: A well conducted evaluation and counseling may help in treatment, for a better quality of life of these patients.

Entities:  

Mesh:

Year:  2011        PMID: 22218518     DOI: 10.1590/s1413-86702011000600013

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  12 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Response to: RSBMT-2018-0270.R2 - Pain and quality of life in human T cell lymphotropic virus type 1 associated myelopathy or tropical spastic paraparesis after home-based exercise protocol: Randomized clinical trial.

Authors:  Maíra Carvalho Macêdo; Renata de Sousa Mota; Naiane Araújo Patrício; Abrahão Fontes Baptista; Antônio de Souza Andrade Filho; Katia Nunes Sá
Journal:  Rev Soc Bras Med Trop       Date:  2022-06-06       Impact factor: 2.141

3.  Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms.

Authors:  Glória O Orge; Thais R Dellavechia; José Abraão Carneiro-Neto; Lucas Araújo-de-Freitas; Carla H C Daltro; Carlos T Santos; Lucas C Quarantini
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 4.  Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives.

Authors:  Katia N Sá; Maíra C Macêdo; Rosana P Andrade; Selena D Mendes; José V Martins; Abrahão F Baptista
Journal:  J Multidiscip Healthc       Date:  2015-02-23

5.  Estimation of HTLV-1 vertical transmission cases in Brazil per annum.

Authors:  Carolina Rosadas; Bassit Malik; Graham P Taylor; Marzia Puccioni-Sohler
Journal:  PLoS Negl Trop Dis       Date:  2018-11-12

6.  Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.

Authors:  Carolina Rosadas; Tatiane Assone; Marina Yamashita; Adine Adonis; Marzia Puccioni-Sohler; Marisa Santos; Arthur Paiva; Jorge Casseb; Augusto C P Oliveira; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

Review 7.  Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies.

Authors:  Carolina Rosadas; Maria Luiza B Menezes; Bernardo Galvão-Castro; Tatiane Assone; Angélica E Miranda; Mayra G Aragón; Adele Caterino-de-Araujo; Graham P Taylor; Ricardo Ishak
Journal:  PLoS Negl Trop Dis       Date:  2021-09-23

8.  Association between Cognitive Function and Depression with Human T-Cell Lymphotropic Virus 1 Seropositivity and Serointensity in UK Adults.

Authors:  Lance D Erickson; Dawson W Hedges; Bruce L Brown; Bradley Embley; Shawn D Gale
Journal:  Pathogens       Date:  2021-10-30

9.  The Influence of Coinfection on Mood States in HTLV-1-Infected Patients.

Authors:  Maria Rita Polo Gascón; Claudio Garcia Capitão; Maria Cezira Fantini Nogueira-Martins; Jorge Casseb; Augusto Cesar Penalva Oliveira
Journal:  ISRN Psychiatry       Date:  2012-07-01

10.  HAM/TSP and major depression: the role of age.

Authors:  Ney Boa-Sorte; Ana Verena Galvão-Castro; Danilo Borba; Renan Barbalho Nunes de Castro Lima; Bernardo Galvão-Castro
Journal:  Braz J Infect Dis       Date:  2015-01-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.